Nascent Bolsters Stevia Supply Amid COVID-19 Global Supply Chain Shortages
An upsurge in demand for sugar alternatives, coupled with production and logistical challenges posed by the COVID-19 pandemic, have caused significant supply chain disruptions for ingredients such as steviol glycosides, crystalline allulose, and erythritol. Product shortages have also caused longer lead times and prices have increased, further exacerbating matters for many manufacturers of food and beverage products dependent upon sweetener ingredients.
Here at Nascent, we have been focused on reinforcing the availability of our broad range of ingredients, including all grades of stevia from Reb A through Reb M — in both conventional and certified organic varieties — as well as a complete portfolio of 1:1 sugar replacement solutions. While some ingredient companies and suppliers have struggled with delays and shortages due to the continued fallout from COVID-19, we are pleased to inform customers that we are fully stocked on all stevia extracts, blends and flavors. Our inventory levels remain abundant in all our warehouses across the US, with dozens of metric tons of product available today.
Nascent’s availability of supply is largely thanks to our continuous R&D efforts with Zhucheng Haotian Pharm Co., Ltd. (ZCHT), the world’s largest manufacturer of natural stevia extracts. Along with manufacturing economies of scale and its abundance of leaf supply, ZCHT couples high-efficiency extraction methods with high-yielding plant varieties to achieve the most economical and sustainable portfolio of targeted glycosides.
In addition to meeting supply shortages in this challenging market, Nascent has continued providing strategic consultation services with our customers on optimal formulation solutions, managing changing costs for ingredients and forecasting consumption trends.
For more information regarding our available ingredients and formulation advisory services, please reach out and connect with the Nascent Health Sciences team.